Literature DB >> 34779883

Impact of positive vascular margins status after surgical resection of non-metastatic renal cell carcinoma with caval tumour thrombus: a propensity score multicentre study.

Jonathan Olivier1, Zine-Eddine Khene2,3, Nicolas Vamour4, Anis Gasmi2, Xavier Leroy5, Philippe Puech6, Mohamed Koussa7, Arnauld Villers1,8, Jean-Christophe Fantoni1, Nicolas Doumerc9, Karim Bensalah2.   

Abstract

BACKGROUND: Data evaluating the impact of positive vascular margins (PVMs) following surgical resection of non-metastatic renal cell carcinoma (RCC) with inferior vena cava (IVC) tumor thrombus are lacking.
OBJECTIVE: To analyze the oncological impact of positive vascular margins following surgical resection of RCC with IVC tumor thrombus.
METHODS: Patients who underwent radical nephrectomy with the removal of IVC tumour thrombus for RCC between 2000 and 2019 were included. PVMs were identified from pathology reports defined as microscopically identified tumour present in the IVC wall at the site of resection or in case of thrombus was not completely removed. To achieve balance in baseline characteristics between patients with PVMs versus negative vascular margins, we used inverse probability of treatment weighting (IPTW) based on the propensity score. Local recurrence, distant metastasis and overall mortality were evaluated between groups using Cox proportional hazards regression models.
RESULTS: 209 patients were analyzed. Among them, 49 (23%) patients with PVMs were identified. Median follow-up was 55 months. After adjustment, excellent balance was achieved for most propensity score variables. In IPTW analysis, PVMs was associated with a higher risk of local recurrence (HR = 3.66; p < 0.001) without any impact on systemic recurrence (HR = 1.15; p = 0.47) or overall mortality (HR = 1.23; p = 0.48). Limitations include the sample size and unmeasured confounding.
CONCLUSION: Our results suggest that a PVMs in patients with RCC after nephrectomy with thrombectomy is associated with a higher risk of local recurrence, however, it did not appear to influence the risk of distant metastasis or death.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Kidney cancer; Positive margin; Prognosis; Recurrence; Renal cell carcinoma; Thrombus

Mesh:

Year:  2021        PMID: 34779883     DOI: 10.1007/s00345-021-03880-6

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  18 in total

1.  Adjusted survival curves with inverse probability weights.

Authors:  Stephen R Cole; Miguel A Hernán
Journal:  Comput Methods Programs Biomed       Date:  2004-07       Impact factor: 5.428

2.  European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update.

Authors:  Börje Ljungberg; Laurance Albiges; Yasmin Abu-Ghanem; Karim Bensalah; Saeed Dabestani; Sergio Fernández-Pello; Rachel H Giles; Fabian Hofmann; Milan Hora; Markus A Kuczyk; Teele Kuusk; Thomas B Lam; Lorenzo Marconi; Axel S Merseburger; Thomas Powles; Michael Staehler; Rana Tahbaz; Alessandro Volpe; Axel Bex
Journal:  Eur Urol       Date:  2019-02-23       Impact factor: 20.096

3.  Positive vascular wall margins have minimal impact on cancer outcomes in patients with non-metastatic renal cell carcinoma (RCC) with tumour thrombus.

Authors:  E Jason Abel; Alonso Carrasco; Jose Karam; Pheroze Tamboli; Scott Delacroix; Ara A Vaporciyan; Christopher G Wood
Journal:  BJU Int       Date:  2014-02-19       Impact factor: 5.588

4.  Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.

Authors:  J Ferlay; E Steliarova-Foucher; J Lortet-Tieulent; S Rosso; J W W Coebergh; H Comber; D Forman; F Bray
Journal:  Eur J Cancer       Date:  2013-02-26       Impact factor: 9.162

5.  Surgical treatment of renal cancer with vena cava extension.

Authors:  R J Neves; H Zincke
Journal:  Br J Urol       Date:  1987-05

6.  The Prognostic Impact of a Positive Vascular Margin on pT3 Clear Cell Renal Cell Carcinoma.

Authors:  Nick W Liu; James D Wren; Emily Vertosick; Justin K Lee; Nicholas E Power; Nicole E Benfante; Simon Y Kimm; Manjit S Bains; Daniel D Sjoberg; Paul Russo; Jonathan A Coleman
Journal:  J Urol       Date:  2015-09-10       Impact factor: 7.450

7.  The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus.

Authors:  Michael L Blute; Bradley C Leibovich; Christine M Lohse; John C Cheville; Horst Zincke
Journal:  BJU Int       Date:  2004-07       Impact factor: 5.588

Review 8.  A critical analysis of surgery for kidney cancer with vena cava invasion.

Authors:  Ziya Kirkali; Hein Van Poppel
Journal:  Eur Urol       Date:  2007-05-24       Impact factor: 20.096

9.  The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments.

Authors:  Peter C Austin
Journal:  Stat Med       Date:  2013-09-30       Impact factor: 2.373

10.  Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples.

Authors:  Peter C Austin
Journal:  Stat Med       Date:  2009-11-10       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.